CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 41 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $119,000 | -16.8% | 47,793 | -0.5% | 0.02% | -10.0% |
| Q2 2021 | $143,000 | -15.4% | 48,025 | -0.1% | 0.02% | -23.1% |
| Q1 2021 | $169,000 | -26.2% | 48,072 | -0.1% | 0.03% | -27.8% |
| Q4 2020 | $229,000 | +15.1% | 48,129 | +17.8% | 0.04% | -14.3% |
| Q3 2020 | $199,000 | +49.6% | 40,851 | -0.1% | 0.04% | +31.2% |
| Q2 2020 | $133,000 | -90.9% | 40,882 | -87.3% | 0.03% | -90.0% |
| Q4 2019 | $1,466,000 | -25.5% | 321,394 | -0.0% | 0.32% | -31.1% |
| Q3 2019 | $1,968,000 | +6.6% | 321,500 | +6.0% | 0.47% | +17.1% |
| Q2 2019 | $1,847,000 | +10.1% | 303,289 | +0.4% | 0.40% | +8.7% |
| Q1 2019 | $1,677,000 | -3.0% | 302,127 | -1.0% | 0.37% | -20.4% |
| Q4 2018 | $1,728,000 | -37.4% | 305,222 | +16.0% | 0.46% | -27.6% |
| Q3 2018 | $2,762,000 | -5.7% | 263,065 | -0.3% | 0.64% | -24.9% |
| Q2 2018 | $2,929,000 | +81.5% | 263,894 | +30.8% | 0.84% | +47.0% |
| Q1 2018 | $1,614,000 | – | 201,698 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,030,533 | $22,539,000 | 4.01% |
| ARS Investment Partners, LLC | 796,367 | $8,840,000 | 1.41% |
| Gagnon Advisors, LLC | 194,579 | $2,160,000 | 1.37% |
| GAGNON SECURITIES LLC | 263,894 | $2,929,000 | 0.84% |
| Benchmark Capital Advisors | 96,235 | $1,068,000 | 0.81% |
| PERKINS CAPITAL MANAGEMENT INC | 94,550 | $1,050,000 | 0.75% |
| Cortina Asset Management, LLC | 645,718 | $7,167,000 | 0.34% |
| EAM Investors, LLC | 73,327 | $814,000 | 0.13% |
| Whitegate Investment Counselors, Inc. | 11,000 | $122,000 | 0.02% |
| ROYCE & ASSOCIATES LP | 299,353 | $3,323,000 | 0.02% |